Rethinking Uveal Melanoma Surveillance

Share

1

A study of 1086 uveal melanoma patients suggests that hepatic surveillance may be effective for only five years post-treatment.
2

29% of patients developed liver metastases, with 93% detected within the first five years of surveillance.
3

Surveillance protocols currently impose significant imaging burdens, particularly with the use of MRI in resource-constrained systems.
4

Increasing T stage and tumor location significantly influence metastatic risk, indicating a need for tailored follow-up.
5

The study advocates for rethinking surveillance protocols to focus on personalized strategies rather than a one-size-fits-all approach.